NASDAQ:IMI

Intermolecular (IMI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.20
$1.20
50-Day Range
$1.20
$1.20
52-Week Range
$0.88
$1.25
Volume
N/A
Average Volume
57,852 shs
Market Capitalization
$59.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IMI stock logo

About Intermolecular Stock (NASDAQ:IMI)

Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

IMI Stock News Headlines

IMI plc IMI
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
MSCI ACWI IMI (MIWD000I0PUS)
Simple covalent molecules
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
IMI_old Historical Data
Weekly 3-Year Low Highlights: STRA, IMI, HXM, SPHS
See More Headlines
Receive IMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intermolecular and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/08/2019
Today
4/26/2024

Industry, Sector and Symbol

Industry
Semiconductors & Related Devices
Sub-Industry
Semiconductors
Current Symbol
NASDAQ:IMI
CUSIP
45882D10
Fax
N/A
Employees
88
Year Founded
N/A

Profitability

Net Income
$-3,410,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$33.66 million
Cash Flow
$0.03 per share
Book Value
$0.69 per share

Miscellaneous

Free Float
N/A
Market Cap
$59.71 million
Optionable
Not Optionable
Beta
0.93
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Christian F. Kramer (Age 57)
    Pres, CEO & Director
  • Mr. Bill Roeschlein (Age 49)
    Sr. VP & CFO
  • Mr. Milind Weling
    Sr. VP of Programs & Operations
  • Dr. Karl Littau
    Chief Technology Officer
  • Mr. Joe Montano
    Sr. VP of Customer Enablement

IMI Stock Analysis - Frequently Asked Questions

How were Intermolecular's earnings last quarter?

Intermolecular Inc (NASDAQ:IMI) posted its quarterly earnings data on Thursday, August, 8th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.08. The semiconductor company had revenue of $4.62 million for the quarter. Intermolecular had a negative trailing twelve-month return on equity of 33.13% and a negative net margin of 42.74%.

What other stocks do shareholders of Intermolecular own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intermolecular investors own include A.H. Belo (AHC), Aerojet Rocketdyne (AJRD), Antares Pharma (ATRS), Genetic Technologies (GENE), CarMax (KMX), Liquidity Services (LQDT), Orion Energy Systems (OESX), Profire Energy (PFIE), CafePress (PRSS) and Payment Data Systems (PYDS).

This page (NASDAQ:IMI) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners